Mostrando 10 resultados de: 11
Filtros aplicados
Subtipo de publicación
Article(11)
Publisher
The Lancet(3)
American Heart Journal(1)
European Heart Journal(1)
European Heart Journal - Quality of Care and Clinical Outcomes(1)
Heart(1)
Área temáticas
Enfermedades(6)
Farmacología y terapéutica(6)
Problemas sociales y servicios a grupos(4)
Medicina forense; incidencia de enfermedades(2)
Dirección general(1)
Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data
ArticleAbstract: Background Hypertension is considered the most important risk factor for cardiovascular diseases, buPalabras claves:Autores:Agapay D., Alhabib K.F., Aliberti A., Aoucheva N., Attaei M.W., Auger D., Avezum A.J., Azad A.K., Bahonar A., Casaccia G., Casanova A., Cherry H.M., Chin S.L., Choudhury T., Chow C.K., Dagenais G.R., Dayal L., Dehghan M., Dejesus J., Devanath A., DIaz R., Elsheikh W., Gupta R., Hall K., Haque R., Hari D., Hassan I., Heldman L., Hu W., Hussain F., Igumbor E.U., Islam S., Joseph P.G., Kandy N., Kaur M., Kay I., Keneth J., Keys J., Khan M.U., Khatib R., Kruger L., Kutty R., Lanas F.T., Lear S.A., Leong D.P., Lewis B.S., Lewis G., Lindeman J., Linetsky B., Mackie P., Maini Cuneo J.M., Mannan A., Marcilio C.S., Mattos A.C., Mckee M., McQueen M.J., Mente A., Milazzo E., Mohan V., Mushtaha M., Oguz A., Oliveira G.B.F., Orlandini A., O’Donnell M., Parvin S., PATRICIO LOPEZ -JARAMILLO, Poirier P., Rabbani K.A., Rahman O., Ramacham S., Ramasundarahettige C., Ramezani E., Rangarajan S., Reyes A., Rimac J., Rosengren A., Shahrook S., Shifaly F., Sintaha M., Smyth A., Solano R., Swallow J., Szuba A., Talukdar A.T., Teo K.K., Tongana T., Tooheen R.B., Toscanelli S., Trottier M., Trottier S., Turbide G., Wang X., Wong G.W.K., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M., Zaki A., Zhang B., Zhang M.Fuentes:googlescopusFixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis
ArticleAbstract: Background: In randomised controlled trials, fixed-dose combination treatments (or polypills) have bPalabras claves:Autores:Avezum A.J., Bangdiwala S.I., Bosch J.J., Castellano J.M., Dagenais G.R., Dans A.M., DIaz R., Fuster V., Gamra H., Gao P., Huffman M.D., Joseph P.G., Liu L., Lonn E.M., Malekzadeh R., Pais P., PATRICIO LOPEZ -JARAMILLO, Prabhakaran D., Rodgers A., Roshandel G., Sliwa K., Teo K.K., Xavier D., Yusuf S., Zhu J.Fuentes:googlescopusEffects of a Polypill, Aspirin, and the Combination of Both on Cognitive and Functional Outcomes: A Randomized Clinical Trial
ArticleAbstract: Importance: Vascular risk factors are associated with cognitive decline but studies addressing indivPalabras claves:Autores:Bosch J.J., Dans A.M., Gao P., Joseph P.G., O'donnell M.J., Pais P., PATRICIO LOPEZ -JARAMILLO, Xavier D., Yusuf S.Fuentes:scopusLowering cholesterol, blood pressure, or both to prevent cardiovascular events: Results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants
ArticleAbstract: Aims: Rosuvastatin (10 mg per day) compared with placebo reduced major adverse cardiovascular (CV) ePalabras claves:Cardiovascular disease, Primary Prevention, statinsAutores:Avezum A.J., Bosch J.J., Dagenais G.R., Dans A.M., DIaz R., Held C., Jansky P., Joseph P.G., Jung H., Keltai K., Keltai M., Khunti K., Leiter L.A., Lewis B.S., Liu L., Lonn E.M., Pais P., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Peters R.J.G., Piegas L.S., Reid C.M., Sliwa K., Toff W.D., Varigos J.D., Xavier D., Yusoff K., Yusuf S., Zhu J.Fuentes:googlescopusModifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
ArticleAbstract: Background: Global estimates of the effect of common modifiable risk factors on cardiovascular diseaPalabras claves:Autores:Alhabib K.F., Avezum A.J., Bo H., Brauer M., Chifamba J., Dagenais G.R., Dans A.M., DIaz R., Gupta R., Hystad P., Iqbal R., Islam S., Joseph P.G., Kaur M., Kelishadi R., Khatib R., Kruger L., Kutty V.R., Lanas F.T., Lear S.A., Leong D.P., Mckee M., Mente A., Mohan V., Mony P.K., Oguz A., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rahman O., Rangarajan S., Rosengren A., Teo K.K., Wei L., Wielgosz A., Yeates K.E., Yusoff K., Yusuf S., Yusufali A.M., Zatońska K.Fuentes:googlescopusVariations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study
ArticleAbstract: Background: To our knowledge, no previous study has prospectively documented the incidence of commonPalabras claves:Autores:Alhabib K.F., Avezum A.J., Chifamba J., Dagenais G.R., DIaz R., Gupta R., Joseph P.G., Kaur M., Kazmi K., Kelishadi R., Khatib R., Lanas F.T., Leong D.P., Mohan V., Mony P.K., Noorhassim I., Oliveira G.B.F., Parambath S.R., PATRICIO LOPEZ -JARAMILLO, Rahman O., Rangarajan S., Rosengren A., Temizhan A., Teo K.K., Vijayakumar K., Wei L., Wielgosz A., Yeates K.E., Yusuf S., Yusufali A.M., Zatońska K., Zhu J.Fuentes:googlescopusVitamin D supplementation and adverse skeletal and non-skeletal outcomes in individuals at increased cardiovascular risk: Results from the International Polycap Study (TIPS)-3 randomized controlled trial
ArticleAbstract: Background and aims: Vitamin D has mostly been tested in Western populations. We examined the effectPalabras claves:Cáncer, Cardiovascular disease, death, Falls, fractures, vitamin DAutores:Bosch J., Christou C., Dagenais G.R., Dans A.M., Gamra H., Gao P., Joseph P.G., Pais P., PATRICIO LOPEZ -JARAMILLO, Santoso A., Talukder S.H., Teo K., Tyrwhitt J., Xavier D., Yusoff K., Yusuf S.Fuentes:googlescopusPrognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the world
ArticleAbstract: Objective To evaluate the performance of the non-laboratory INTERHEART risk score (NL-IHRS) to pbkp_Palabras claves:Cardiovascular disease, INTERHEART risk score, risk pbkp_redictionAutores:Anand S.S., Avezum A.J., Chifamba J., DIaz R., Gulec S., Guo B., Gupta R., Ibrahim Q., Iqbal R., Joseph P.G., Krishnapillai A., Kruger A., Kumar R., Lanas F., Lear S.A., Lee S.F., Liu X., Mohammadifard N., Mohan V., Mony P.K., PATRICIO LOPEZ -JARAMILLO, Pillai R.K., Rangarajan S., Rosengren A., Szuba A., Teo K.K., Yang Y., Yusuf R., Yusuf S., Yusufali A.M., Zhao W.Fuentes:googlescopusPolypill with or without aspirin in persons without cardiovascular disease
ArticleAbstract: BACKGROUND A polypill comprising statins, multiple blood-pressure-lowering drugs, and aspirin has bePalabras claves:Autores:Bosch J.J., Christou C., Dagenais G.R., Dans A.M., Gamra H., Gao P., Girish P., Joseph P.G., McCready T., Pais P., PATRICIO LOPEZ -JARAMILLO, Rocha C., Santoso A., Talukder S.H., Teo K.K., Tyrwhitt J., Xavier D., Xavier F., Yeates K.E., Yusoff K., Yusuf S.Fuentes:googlescopusThe International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conduct
ArticleAbstract: Background: It is hypothesized that in individuals without clinical cardiovascular disease (CVD), buPalabras claves:Autores:Bosch J.J., Dans A.M., Gamra H., Gao P., Joseph P.G., Lopez P.C., Pais P., PATRICIO LOPEZ -JARAMILLO, Santoso A., Talukder S.H., Teo K.K., Tyrwhitt J., Xavier D., Yeates K.E., Yusoff K., Yusuf S.Fuentes:googlescopus